Clinical Trial Update: Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial [Phase 3]

View source ↗

Summary

Phase 3 trial of olanzapine augmentation for treatment-resistant depression was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: University Hospital Freiburg | Conditions: Therapy-resistant Depression | Phase 3 | Status: WITHDRAWN